Prognose des europäischen Bioprozessmarkts bis 2031 – Regionale Analyse – nach Produkt (Instrumente, Verbrauchsmaterialien und Zubehör), Betriebsgröße (kommerzieller Betrieb und klinischer Betrieb), Prozess (Downstream-Bioprozess und Upstream-Bioprozess), Anwendung (monoklonale Antikörper, Impfstoffe, rekombinante Proteine, Zell- und Gentherapie und andere) und Endverbraucher (biopharmazeutische Unternehmen, Auftragsfertigungsorganisationen und andere)

BMIRE00030824 | Pages: 167 | Biotechnology | Oct 2024 | Type: Regional | Status: Published
Der europäische Bioprozessmarkt wurde im Jahr 2023 auf 6.216,50 Millionen US-Dollar geschätzt und soll bis 2031 16.803,47 Millionen US-Dollar erreichen; es wird geschätzt, dass er von 2023 bis 2031 eine durchschnittliche jährliche Wachstumsrate von 13,2 % verzeichnet.

Wachsende biopharmazeutische Industrie treibt europäischen Bioprozessmarkt an

In der biopharmazeutischen Industrie sind immer verbesserte Bioprozesse gefragt, um neue regulatorische Anforderungen, Qualitätskontrollanforderungen und Produktionsprobleme bei biologischen Produkten, Zellkulturtitration und Biosimilar-Produktion zu erfüllen. In den letzten Jahren ist die biopharmazeutische Industrie in beispiellosem Tempo gewachsen. Biopharmazeutische Unternehmen geben enorme Summen für Forschung und Entwicklung aus, um neue Moleküle mit verbesserter medizinischer und kommerzieller Wirksamkeit für verschiedene therapeutische Anwendungen einzuführen. Die Akzeptanz der Bioverarbeitung nimmt aufgrund ihrer breiten Anwendung in der Forschung, Entwicklung und Herstellung von Biologika und Biosimilars allmählich zu. Große Pharmaunternehmen und Auftragsforschungsinstitute entwickeln neue Medikamente und Therapieformen zur Behandlung einer breiten Palette von Indikationen. Darüber hinaus treibt eine starke Nachfrage nach Biologika und Biosimilars zur Behandlung chronischer Krankheiten wiederum das Wachstum der biopharmazeutischen Industrie voran. Die biopharmazeutische Industrie ist einer der wichtigsten Wirtschaftsfaktoren. Faktoren wie die zunehmende Zulassung von Biologika, die wachsende Biosimilar-Pipeline, steigende Investitionen in Forschungsaktivitäten und ein zunehmender Fokus auf die Entwicklung erschwinglicher Biologika fördern das Wachstum der biopharmazeutischen Industrie.

Abgesehen davon fördern zunehmende Zulassungen von Gen- und Zelltherapien das Wachstum des Bioprozessmarktes. Die zugelassenen Gentherapien sind Glybera (zur Behandlung von Lipoproteinlipasemangel) und Strimvelis (zur Behandlung von ADA-bedingter schwerer kombinierter Immundefizienz). Somit erhöhen die oben genannten Faktoren die Nachfrage nach der Massenproduktion verschiedener Therapeutika und fördern so das Wachstum des Bioprozessmarktes.

Überblick über den europäischen Bioprozessmarkt

Biosimilars sorgen für Wettbewerb und erhöhen die Erschwinglichkeit von Biologika, was letztlich zu Einsparungen und Mehrwertdiensten zur Unterstützung der Patientenversorgung und der Gesundheitsbranche führt. Angehörige der Gesundheitsberufe können mehr Patienten mit hochwertigen Biologika zu geringeren Kosten behandeln. Aufgrund des enormen Kosteneinsparungspotenzials hat das deutsche Gesundheitsministerium ein neues Gesetz zur Förderung der Einführung von Biosimilars erlassen. Auch eine wachsende Zahl von Partnerschaften zwischen internationalen Akteuren fördert das Marktwachstum im Land. So haben beispielsweise Hitachi Chemical Advanced Therapeutics Solutions, LLC und apceth Biopharma GmbH im November 2020 ihre Beziehung zu Bluebird Bio ausgebaut, um langfristige Entwicklungs- und Produktionsdienstleistungsverträge für die klinische und kommerzielle Versorgung mehrerer Therapien abzuschließen und die Produktionskapazität für kommerzielle Arzneimittelprodukte in Europa für ZYNTEGLO, eine einmalige Gentherapie für transfusionsabhängige β-Thalassämie (TDT), zu erweitern. Darüber hinaus verzeichnet der Biotechnologiesektor in Deutschland ein enormes Wachstum, was auf die Präsenz zahlreicher Biotechnologieunternehmen, hochtechnologischer Forschungslabore und massiver Forschungs- und Entwicklungsfinanzierungen zurückzuführen ist. Das Wachstum der Forschung und Entwicklung im Bereich Biopharmazeutika und Biologika wird vor allem durch die Einführung verschiedener Biostrategien durch Unternehmen der Gesundheitsbranche vorangetrieben. So erweiterte Rentschler Biopharma im Juni 2021 seine Produktionskapazität um einen 2.000-Liter-Bioreaktor, um der steigenden Nachfrage nach komplexen Antikörpern gerecht zu werden, einer Klasse biopharmazeutischer Arzneimittel mit weiterhin hohem Potenzial. Ebenso arbeitete Sartorius, einer der führenden Zulieferer für die biopharmazeutische Industrie, im August 2023 mit dem globalen Technologie- und Softwareführer Emerson zusammen, um die Bioreaktorfamilie Biostat STR Generation 3 von Sartorius mit dem verteilten Steuerungssystem (DCS) DeltaVTM von Emerson zu integrieren. Somit wächst der biopharmazeutische Sektor im Land aufgrund der steigenden F&E-Ausgaben der biopharmazeutischen Unternehmen. Daher beeinflussen gemeinsame Forschungsanstrengungen von Biopharma- und Biotechnologieunternehmen im Land den Markt.

Umsatz und Prognose des europäischen Bioverarbeitungsmarkts bis 2031 (Mio. USD)

Segmentierung des europäischen Bioverarbeitungsmarkts

Der europäische Bioverarbeitungsmarkt ist nach Produkt, Betriebsgröße, Prozess, Anwendung, Endbenutzer und Land kategorisiert.

Basierend auf dem Produkt ist der europäische Bioverarbeitungsmarkt in Instrumente und Verbrauchsmaterialien & Zubehör unterteilt. Das Instrumentensegment hielt 2023 einen größeren Marktanteil. Darüber hinaus ist das Instrumentensegment in Filtrationsgeräte, Bioreaktoren, Chromatographiesysteme, Zentrifugen, Trocknungsgeräte und andere unterteilt. Darüber hinaus ist das Untersegment Bioreaktoren in Pilotmaßstab, Vollmaßstab und Labormaßstab unterteilt. Darüber hinaus ist das Untersegment Chromatographiesysteme in Flüssigkeitschromatographie, Gaschromatographie und andere unterteilt. Darüber hinaus ist das Segment Verbrauchsmaterialien und Zubehör in Reagenzien, Zellkulturmedien, Chromatographieharze und andere unterteilt.

In Bezug auf den Betriebsumfang ist der europäische Bioverarbeitungsmarkt in kommerzielle und klinische Operationen unterteilt. Das Segment kommerzielle Operationen hatte 2023 einen größeren Marktanteil.

Nach Prozess ist der europäische Bioverarbeitungsmarkt in Downstream-Bioprozesse und Upstream-Bioprozesse unterteilt. Das Segment Downstream-Bioprozesse hatte 2023 einen größeren Marktanteil.

Basierend auf der Anwendung ist der europäische Bioverarbeitungsmarkt in monoklonale Antikörper, Impfstoffe, rekombinante Proteine, Zell- und Gentherapie und andere unterteilt. Das Segment monoklonale Antikörper hatte 2023 den größten Marktanteil.

In Bezug auf den Endverbraucher ist der europäische Bioverarbeitungsmarkt in biopharmazeutische Unternehmen, Auftragsfertigungsorganisationen und andere unterteilt. Das Segment der biopharmazeutischen Unternehmen hatte 2023 den größten Marktanteil.

Nach Ländern ist der europäische Bioprozessmarkt in Deutschland, Frankreich, Italien, Großbritannien, Spanien und das übrige Europa unterteilt. Deutschland dominierte 2023 den europäischen Bioprozessmarkt.

Getinge AB, Thermo Fisher Scientific Inc, Sartorius AG, Corning Inc, Bio-Rad Laboratories Inc, Merck KGaA, 3M Co, Eppendorf SE, Repligen Corp, Entegris Inc, Agilent Technologies Inc und Cytiva US LLC. sind einige der führenden Unternehmen auf dem europäischen Bioprozessmarkt.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Bioprocessing Market Landscape

4.1 Ecosystem Analysis

4.1.1 List of Vendors in the Value Chain

5. Europe Bioprocessing Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Chronic Diseases

5.1.2 Growing Biopharmaceutical Industry

5.2 Market Restraints

5.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing

5.3 Market Opportunities

5.3.1 Proliferating Demand for Personalized Medicine

5.4 Future Trends

5.4.1 Shift Toward Automated Cell Therapy Manufacturing

5.5 Impact of Drivers and Restraints:

6. Bioprocessing Market - Europe Analysis

6.1 Europe Bioprocessing Market Overview

6.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

7. Europe Bioprocessing Market Analysis - by Product

7.1 Overview

7.2 Instruments

7.2.1 Overview

7.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

7.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

7.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

7.3 Consumables & Accessories

7.3.1 Overview

7.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

8. Europe Bioprocessing Market Analysis - by Scale of Operation

8.1 Overview

8.2 Commercial Operations

8.2.1 Overview

8.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Clinical Operations

8.3.1 Overview

8.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Bioprocessing Market Analysis - by Process

9.1 Overview

9.2 Downstream Bioprocess

9.2.1 Overview

9.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Upstream Bioprocess

9.3.1 Overview

9.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Bioprocessing Market Analysis - by Application

10.1 Overview

10.2 Monoclonal Antibodies

10.2.1 Overview

10.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.3 Vaccines

10.3.1 Overview

10.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.4 Recombinant Protein

10.4.1 Overview

10.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.5 Cell & Gene Therapy

10.5.1 Overview

10.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.6 Others

10.6.1 Overview

10.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Bioprocessing Market Analysis - by End User

11.1 Overview

11.2 Biopharmaceutical Companies

11.2.1 Overview

11.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.3 Contract Manufacturing Organization

11.3.1 Overview

11.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.4 Others

11.4.1 Overview

11.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Bioprocessing Market - Country Analysis

12.1 Europe

12.1.1 Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

12.1.1.1 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.1.1 Overview

12.1.1.2 Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.2.1 Germany: Bioprocessing Market Breakdown, by Product

12.1.1.2.1.1 Germany: Bioprocessing Market Breakdown, by Instruments

12.1.1.2.1.1.1 Germany: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.2.1.1.2 Germany: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.2.1.2 Germany: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.2.2 Germany: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.2.3 Germany: Bioprocessing Market Breakdown, by Process

12.1.1.2.4 Germany: Bioprocessing Market Breakdown, by Application

12.1.1.2.5 Germany: Bioprocessing Market Breakdown, by End User

12.1.1.3 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.3.1 Overview

12.1.1.4 United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.4.1 United Kingdom: Bioprocessing Market Breakdown, by Product

12.1.1.4.1.1 United Kingdom: Bioprocessing Market Breakdown, by Instruments

12.1.1.4.1.1.1 United Kingdom: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.4.1.1.2 United Kingdom: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.4.1.2 United Kingdom: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.4.2 United Kingdom: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.4.3 United Kingdom: Bioprocessing Market Breakdown, by Process

12.1.1.4.4 United Kingdom: Bioprocessing Market Breakdown, by Application

12.1.1.4.5 United Kingdom: Bioprocessing Market Breakdown, by End User

12.1.1.5 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.5.1 Overview

12.1.1.6 France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.6.1 France: Bioprocessing Market Breakdown, by Product

12.1.1.6.1.1 France: Bioprocessing Market Breakdown, by Instruments

12.1.1.6.1.1.1 France: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.6.1.1.2 France: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.6.1.2 France: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.6.2 France: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.6.3 France: Bioprocessing Market Breakdown, by Process

12.1.1.6.4 France: Bioprocessing Market Breakdown, by Application

12.1.1.6.5 France: Bioprocessing Market Breakdown, by End User

12.1.1.7 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.7.1 Overview

12.1.1.8 Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.8.1 Italy: Bioprocessing Market Breakdown, by Product

12.1.1.8.1.1 Italy: Bioprocessing Market Breakdown, by Instruments

12.1.1.8.1.1.1 Italy: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.8.2 Italy: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.8.2.1 Italy: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.8.3 Italy: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.8.4 Italy: Bioprocessing Market Breakdown, by Process

12.1.1.8.5 Italy: Bioprocessing Market Breakdown, by Application

12.1.1.8.6 Italy: Bioprocessing Market Breakdown, by End User

12.1.1.9 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.9.1 Overview

12.1.1.10 Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.10.1 Spain: Bioprocessing Market Breakdown, by Product

12.1.1.10.1.1 Spain: Bioprocessing Market Breakdown, by Instruments

12.1.1.10.1.1.1 Spain: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.10.1.1.2 Spain: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.10.1.2 Spain: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.10.2 Spain: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.10.3 Spain: Bioprocessing Market Breakdown, by Process

12.1.1.10.4 Spain: Bioprocessing Market Breakdown, by Application

12.1.1.10.5 Spain: Bioprocessing Market Breakdown, by End User

12.1.1.11 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.11.1 Overview

12.1.1.12 Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

12.1.1.12.1 Rest of Europe: Bioprocessing Market Breakdown, by Product

12.1.1.12.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Instruments

12.1.1.12.1.1.1 Rest of Europe: Bioprocessing Market Breakdown, by Bioreactors

12.1.1.12.1.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Chromatography Systems

12.1.1.12.1.2 Rest of Europe: Bioprocessing Market Breakdown, by Consumables & Accessories

12.1.1.12.2 Rest of Europe: Bioprocessing Market Breakdown, by Scale of Operation

12.1.1.12.3 Rest of Europe: Bioprocessing Market Breakdown, by Process

12.1.1.12.4 Rest of Europe: Bioprocessing Market Breakdown, by Application

12.1.1.12.5 Rest of Europe: Bioprocessing Market Breakdown, by End User

13. Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Bioprocessing Market

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Getinge AB

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Thermo Fisher Scientific Inc

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Sartorius AG

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Corning Inc

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Bio-Rad Laboratories Inc

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Merck KGaA

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 3M Co

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Eppendorf SE

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Repligen Corp

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Entegris Inc

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

14.11 Agilent Technologies Inc

14.11.1 Key Facts

14.11.2 Business Description

14.11.3 Products and Services

14.11.4 Financial Overview

14.11.5 SWOT Analysis

14.11.6 Key Developments

14.12 Cytiva US LLC

14.12.1 Key Facts

14.12.2 Business Description

14.12.3 Products and Services

14.12.4 Financial Overview

14.12.5 SWOT Analysis

14.12.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

 

 

?

List of Tables

Table 1. Europe Bioprocessing Market Segmentation

Table 2. List of Vendors

Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

Table 6. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

Table 7. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 8. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 9. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 10. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 11. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 12. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 13. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 14. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 15. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 16. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 17. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 18. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 19. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 20. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 21. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 22. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 23. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 24. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 25. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 26. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 27. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 29. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 30. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 31. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 32. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 33. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 34. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 35. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 36. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 37. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 38. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 39. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 40. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 41. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 42. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 43. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 44. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 45. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 46. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 47. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 48. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 49. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 50. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 51. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 52. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 53. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 54. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 55. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 56. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 57. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 58. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 59. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 60. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 61. Recent Inorganic Growth Strategies in the Bioprocessing Market

Table 62. Recent Organic Growth Strategies in the Bioprocessing Market

Table 63. Glossary of Terms, Bioprocessing Market

 

?

List of Figures

Figure 1. Europe Bioprocessing Market Segmentation, by Country

Figure 2. Bioprocessing Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031

Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)

Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)

Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)

Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)

Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)

Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. Europe: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)

Figure 25. Europe: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 26. Germany: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. United Kingdom: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. France: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 29. Italy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 30. Spain: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 31. Rest of Europe: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 32. Growth Strategies in the Bioprocessing Market

  1. Getinge AB
  2. Thermo Fisher Scientific Inc
  3. Sartorius AG
  4. Corning Inc
  5. Bio-Rad Laboratories Inc
  6. Merck KGaA
  7. 3M Co
  8. Eppendorf SE
  9. Repligen Corp
  10. Entegris Inc
  11. Agilent Technologies Inc
  12. Cytiva US LLC.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe bioprocessing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe bioprocessing market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440